. Expected Benefits to the Listed Company from the Transaction (1) To expand the scope of outsourced production service to cosmetic business; (2) To minimize the reliance on revenues from dietary supplement

parts of the Chonburi Plant, or increasing its capital later on. 8. Expected Benefits to the Listed Company from the Transaction (1) To expand the scope of outsourced production service to cosmetic

achieve a compounded annual growth rate (CAGR) in revenue of approximately 13% per year. The strategic direction to expand the business through mixed-use development, such as new shopping malls, enhancement

global trade volume affected by trade tensions and the impact of structural changes in the Thai economy on export sector. Public expenditure and private investment would expand slower than the previous

shares to 2 new shares. - Loan from financial institution. 8. Expected Benefits for the company 8.1 Will be in accordance with the company’s strategy, to expand into the public infrastructure business by

level of 1.25 percent while projecting the Thai economy would expand at a lower rate than previously forecast and further below its potential due to declining exports which have affected domestic demand

agree to divide payment of the acquisition price as follows: 1) Deposit in the amount of THB 20,000,000 (Twenty Million Baht), which has been duly paid to the Seller as part of the acquisition price; 2

of the Company as well as UAPC in order to expand business in the future, it will enable UAPC to raise funds in the capital market and increase the investment value in UAPC by reflecting actual market

from negotiation between the parties, with reference to valuation of share price by discounted cash flow method. 7. Expected benefits 1) Provide opportunities to the Company to expand its solar power

land with a building worth 125 million baht to expand its production area, warehouse and delivery. The building is still in the process of preparing for readiness to use in the next phase. 2.1.4